Abstract
BACKGROUND:
Relevant factors involved in the pathogenesis of hypertension among dialysis patients include sodium
and water retention, dialysate composition and prescription, increased activity of vasoconstrictive
systems(sympathetic nervous system, rennin-angiotensin system, endothelin and vasopressin),
decrease activity of vasodilatory systems(nitric oxide, kinins), increased intracellular calcium,
increased arterial stiffness, sleep apnea, hyperparathyroidism, erythropoietin and renovascular disease
OBJECTIVE:
The objective of this study is to assess the prevalence of hypertension among uremic patients
undergoing haemodialysis and to assess difference of blood pressure reading before and after
dialysis.
PATIENTS AND METHODS:
140 patients with chronic renal failure ´ renal failure on regular haemodialysis. blood pressure
was measured by doctors before dialysis, within 2 hour of dialysis , after dialysis and after 48 hours
of dialysis. we averaged six routine predialysis systolic and diastolic blood pressure. The same was
carried out for postdialysis.
RESULTS:
Patients with preheamodialysis (office BP) >130/85 mmHg are considered as hypertensive in
chronic renal failure, who made up of 74% of the study population. 40% patients were on
monotherapy antihypertensive drug. 65% are taking calcium channel blocker, angiotensin converting
enzyme inhibitor 38%, angiotensin П receptor blockers 26% and beta blocker 20%.
Preheamodialysis blood pressure(Office BP) overestimated BP values in relation to 48 h postdialysis
CONCLUSION:
Significant difference was shown between predialysis office blood pressure and 48 hour postdialysis
in the recognition of hypertension in heamodialysis patients. the prevalence of hypertension in
heamodialysis patients is high (74%). most of the patients used combination of antihypertensive
drugs, calcium channel blocker commonly used 65%.
Relevant factors involved in the pathogenesis of hypertension among dialysis patients include sodium
and water retention, dialysate composition and prescription, increased activity of vasoconstrictive
systems(sympathetic nervous system, rennin-angiotensin system, endothelin and vasopressin),
decrease activity of vasodilatory systems(nitric oxide, kinins), increased intracellular calcium,
increased arterial stiffness, sleep apnea, hyperparathyroidism, erythropoietin and renovascular disease
OBJECTIVE:
The objective of this study is to assess the prevalence of hypertension among uremic patients
undergoing haemodialysis and to assess difference of blood pressure reading before and after
dialysis.
PATIENTS AND METHODS:
140 patients with chronic renal failure ´ renal failure on regular haemodialysis. blood pressure
was measured by doctors before dialysis, within 2 hour of dialysis , after dialysis and after 48 hours
of dialysis. we averaged six routine predialysis systolic and diastolic blood pressure. The same was
carried out for postdialysis.
RESULTS:
Patients with preheamodialysis (office BP) >130/85 mmHg are considered as hypertensive in
chronic renal failure, who made up of 74% of the study population. 40% patients were on
monotherapy antihypertensive drug. 65% are taking calcium channel blocker, angiotensin converting
enzyme inhibitor 38%, angiotensin П receptor blockers 26% and beta blocker 20%.
Preheamodialysis blood pressure(Office BP) overestimated BP values in relation to 48 h postdialysis
CONCLUSION:
Significant difference was shown between predialysis office blood pressure and 48 hour postdialysis
in the recognition of hypertension in heamodialysis patients. the prevalence of hypertension in
heamodialysis patients is high (74%). most of the patients used combination of antihypertensive
drugs, calcium channel blocker commonly used 65%.
Keywords
Haemodialysis
hypertension
office blood pressure.
postdialysis
predialysis